Seshu Tyagarajan
Chief Tech/Sci/R&D Officer at CANDEL THERAPEUTICS, INC.
Net worth: 231 748 $ as of 30/04/2024
Profile
Seshu Tyagarajan is currently the Chief Technical & Development Officer at Candel Therapeutics, Inc. Prior to this, she worked as the Executive Director & Global Head-CGT at Novartis AG from 2020 to 2022 and as the Global Head-Late Stage CMC Strategy at Novartis Pharmaceuticals from 2019 to 2021.
She holds a doctorate degree from Rutgers State University of New Jersey and a graduate degree from Purdue University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 01/04/2024 | 32,872 ( 0.11% ) | 231 748 $ | 30/04/2024 |
Seshu Tyagarajan active positions
| Companies | Position | Start |
|---|---|---|
| CANDEL THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 02/03/2022 |
Former positions of Seshu Tyagarajan
| Companies | Position | End |
|---|---|---|
| NOVARTIS AG | Director/Board Member | 01/02/2022 |
Novartis Pharmaceuticals
 Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The company is based in Basel, Germany. | Corporate Officer/Principal | 01/03/2021 |
Training of Seshu Tyagarajan
| Rutgers State University of New Jersey | Doctorate Degree |
| Purdue University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CANDEL THERAPEUTICS, INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| Private companies | 1 |
|---|---|
Novartis Pharmaceuticals
Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The company is based in Basel, Germany. | Health Technology |
- Stock Market
- Insiders
- Seshu Tyagarajan
